# Correction: Evaluating the therapeutic efficacy of gastramide theranostics targeting cholecystokinin-2 receptors in a preclinical setting

## TL;DR

This paper corrects a previously published study on gastramide theranostics targeting cholecystokinin-2 receptors in a preclinical setting.

## Contribution

The contribution is the correction of errors in the original study's data or methodology.

## Key findings

- The correction addresses inaccuracies in the original publication.
- It ensures the reliability and accuracy of the reported therapeutic efficacy.

## Abstract

Correction for ‘Evaluating the therapeutic efficacy of gastramide theranostics targeting cholecystokinin-2 receptors in a preclinical setting’ by Marwa N. Rahimi et al., RSC Adv., 2026, 16, 2123–2132, https://doi.org/10.1039/D5RA08789A.